Polycystic Kidney Disease Pipeline Review, H2 2015 Featuring 8 Companies & their Drug Profiles - Research and Markets
February 08 2016 - 7:23AM
Business Wire
Research and Markets
(http://www.researchandmarkets.com/research/58cdcl/polycystic_kidney)
has announced the addition of the "Polycystic Kidney Disease -
Pipeline Review, H2 2015" report to their offering.
This report provides comprehensive information on the
therapeutic development for Polycystic Kidney Disease Prostate
Cancer, complete with comparative analysis at various stages,
therapeutics assessment by drug target, mechanism of action (MoA),
route of administration (RoA) and molecule type, along with latest
updates, and featured news and press releases. It also reviews key
players involved in the therapeutic development for Polycystic
Kidney Disease Prostate Cancer and special features on late-stage
and discontinued projects.
The report enhances decision making capabilities and help to
create effective counter strategies to gain competitive advantage.
It strengthens R&D pipelines by identifying new targets and
MOAs to produce first-in-class and best-in-class products.
Key Topics Covered:
- Introduction
- Polycystic Kidney Disease Prostate Cancer Overview
- Therapeutics Development
- Pipeline Products for Polycystic Kidney Disease Prostate Cancer
- Overview
- Pipeline Products for Polycystic Kidney Disease Prostate Cancer
- Comparative Analysis
- Polycystic Kidney Disease Prostate Cancer - Therapeutics under
Development by Companies
- Polycystic Kidney Disease Prostate Cancer - Therapeutics under
Investigation by Universities/Institutes
- Polycystic Kidney Disease Prostate Cancer - Pipeline Products
Glance
- Late Stage Products
- Clinical Stage Products
- Early Stage Products
- Polycystic Kidney Disease Prostate Cancer - Products under
Development by Companies
- Polycystic Kidney Disease Prostate Cancer - Products under
Investigation by Universities/Institutes
- Polycystic Kidney Disease Prostate Cancer - Companies Involved
in Therapeutics Development
- DiscoveryBiomed, Inc.
- Endocyte, Inc.
- IC-MedTech, Inc.
- Ipsen S.A.
- Kadmon Corporation, LLC
- Metabolic Solutions Development Company, LLC
- Otsuka Holdings Co., Ltd.
- Synta Pharmaceuticals Corp.
For more information visit
http://www.researchandmarkets.com/research/58cdcl/polycystic_kidney
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160208005593/en/
Research and MarketsLaura Wood, Senior
Managerpress@researchandmarkets.comFor E.S.T Office Hours Call
1-917-300-0470For U.S./CAN Toll Free Call 1-800-526-8630For GMT
Office Hours Call +353-1-416-8900U.S. Fax: 646-607-1907Fax (outside
U.S.): +353-1-481-1716Sector: Pharmaceuticals, Liver and Kidney
Disorders